APOC4 and hyperlipidemia: The present study demonstrated a significant upregulation in several apolipoproteins, including APOC1, APOB, APOC4 and APOL1, but also in LCAT (Figure 5), suggesting a dysregulation in lipoprotein metabolism that could be partially related to the hyperlipidemia in IMN patients.